Treace Medical Concepts, INC 10-K annual reports

Treace Medical Concepts, Inc. reported a net loss of $59.0 million for fiscal year 2025, despite a slight revenue increase and new product introductions in the competitive bunion correction market.

Treace Medical Concepts' 2024 10-K filing reveals a year of revenue growth alongside continued net losses, highlighting strategic investments in product innovation and market penetration within the bunion and midfoot correction market.

Treace Medical Concepts updates its non-employee director compensation program and files its annual report, highlighting financial performance and strategic initiatives.